1. Bellack A, “Psychosocial treatment in schizophrenia.” Dialogues in Clinical Psychology [Internet] 2001 Jun [cited 2022 June 20]
2. Kesby JP, Eyles DW, McGrath JJ, Scott JG. Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience. Transl Psychiatry. 2018 Jan 31;8(1):30. doi: 10.1038/s41398-017-0071-9. PMID: 29382821; PMCID: PMC5802623. [cited 2023 April 20]
3. Kerner B. (2009). Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse. The open psychiatry journal, 3, 1–8. https://doi.org/10.2174/1874354400903010001 [cited 2023 April 20]
4. Sahoo, S., Mehra, A., & Grover, S. (2016). Acute Hyperglycemia Associated with Psychotic Symptoms in a Patient with Type 1 Diabetes Mellitus: A Case Report. Innovations in clinical neuroscience, 13(11-12), 25–27. [cited 2023 April 20]
5). Brown A. S. (2011). The environment and susceptibility to schizophrenia. Progress in neurobiology, 93(1), 23–58. https://doi.org/10.1016/j.pneurobio.2010.09.003 [cited 2023 April 20]
6) NAMI authors,. “What Are Possible Side Effects Of Aripiprazole?”. National Alliance on Mental Illness, published online Jan 2016 [cited 2022 June 20]
7. FDA Label Abilify (aripiprazole) as revised 2014 December [cited 2022 June 20]
8. Maglione M, Maher AR, Hu J, Wang Z, Shanman R, Shekelle PG, Roth B, Hilton L, Suttorp MJ, Ewing BA, Motala A, Perry T. Off-Label Use of Atypical Antipsychotics: An Update [Excerpt] Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Sep. Report No.: 11-EHC087-EF. PMID: 22132426. [cited 2022 June 20]
9. Shirzadi AA, Ghaemi SN. Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome. Harv Rev Psychiatry. 2006 May-Jun;14(3):152-64. doi: 10.1080/10673220600748486. PMID: 16787887. [cited 2023 April 20]
10. Pizzorno J. (2016). Can We Say “Cure”?. Integrative medicine (Encinitas, Calif.), 15(5), 8–12. [cited 2023 April 20]
11. Turkington D, Dudley R, Warman DM, Beck AT. Cognitive-behavioral therapy for schizophrenia: a review. J Psychiatr Pract. 2004 Jan;10(1):5-16. doi: 10.1097/00131746-200401000-00002. PMID: 15334983.[cited 2022 June 20]
12. Rector NA, Beck AT. Cognitive behavioral therapy for schizophrenia: an empirical review. J Nerv Ment Dis. 2001 May;189(5):278-87. doi: 10.1097/00005053-200105000-00002. PMID: 11379970. [cited 2022 June 20]
13. Cunningham JEA, Shapiro CM. Cognitive Behavioural Therapy for Insomnia (CBT-I) to treat depression: A systematic review. J Psychosom Res. 2018 Mar;106:1-12. doi: 10.1016/j.jpsychores.2017.12.012. Epub 2017 Dec 24. PMID: 29455893. [cited 2022 June 20]
14. Schuch FB, Vancampfort D. Physical activity, exercise, and mental disorders: it is time to move on. Trends Psychiatry Psychother. 2021 Jul-Sep;43(3):177-184. doi: 10.47626/2237-6089-2021-0237. Epub 2021 Apr 21. PMID: 33890431; PMCID: PMC8638711. [cited 2024 Jan 11]
15. Dharmayani PNA, Juergens M, Allman-Farinelli M, Mihrshahi S. Association between Fruit and Vegetable Consumption and Depression Symptoms in Young People and Adults Aged 15-45: A Systematic Review of Cohort Studies. Int J Environ Res Public Health. 2021 Jan 18;18(2):780. doi: 10.3390/ijerph18020780. PMID: 33477603; PMCID: PMC7831325. [cited 2024 Jan 11]
16. Yuan X, Kang Y, Zhuo C, Huang XF, Song X. The gut microbiota promotes the pathogenesis of schizophrenia via multiple pathways. Biochem Biophys Res Commun. 2019 Apr 30;512(2):373-380. doi: 10.1016/j.bbrc.2019.02.152. Epub 2019 Mar 18. PMID: 30898321.[cited 2022 June 20]
17. Evans GW. The built environment and mental health. J Urban Health. 2003 Dec;80(4):536-55. doi: 10.1093/jurban/jtg063. PMID: 14709704; PMCID: PMC3456225. [cited 2022 June 20]
18. Hoffer, A. Megavitamin B-3 Therapy for Schizophrenia. Canadian Psychiatric Association Journal, Volume: 16 issue: 6, page(s): 499-504 December 1, 1971 [cited 2022 June 20]
19. Learning and Developmental Disabilities Initiative of the CDC, Mental Health and Environmental Exposures. published November.2008 [cited 2022 June 20]
20. Low Dog T. The role of nutrition in mental health. Altern Ther Health Med. 2010 Mar-Apr;16(2):42-6. PMID: 20232617. [cited 2022 June 20]
21. Kraal A Z et al., Could Dietary Glutamate Play a Role in Psychiatric Distress? Journal of Neurpsychobiology 2020; 79: 13-10 published February 2020 [cited 2022 June 20]
22. Knüppel A, Shipley MJ, Llewellyn CH, Brunner EJ. Sugar intake from sweet food and beverages, common mental disorder and depression: prospective findings from the Whitehall II study. Sci Rep. 2017;7(1):6287. Published 2017 Jul 27. doi:10.1038/s41598-017-05649-7 [cited 2022 June 20]
23. Guo X, Park Y, Freedman ND, et al. Sweetened beverages, coffee, and tea and depression risk among older US adults.PLoS One. 2014;9(4):e94715. Published 2014 Apr 17. doi:10.1371/journal.pone.0094715 [cited 2022 June 20]
24. Dazzan, P., Morgan, K., Orr, K.et al. Different Effects of Typical and Atypical Antipsychotics on Grey Matter in First Episode Psychosis: the ÆSOP Study. Neuropsychopharmacol 30,765–774 (2005). https://doi.org/10.1038/sj.npp.1300603 [cited 2022 June 20]
25. Prousky, Jonathan. (2014). The Clinical use of Orthomolecules in the Treatment of Schizophrenia: Critical Reflections and Commentary. Journal of Orthomolecular Medicine. 29. 141-153. [cited 2022 June 20]
26. Klauser, P., Xin, L., Fournier, M.et al. N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial. Transl Psychiatry 8,220 (2018). https://doi.org/10.1038/s41398-018-0266-8 [cited 2022 June 20]
27. Aucoin M, LaChance L, Clouthier SN, Cooley K. Dietary modification in the treatment of schizophrenia spectrum disorders: A systematic review. World J Psychiatry. 2020 Aug 19;10(8):187-201. doi: 10.5498/wjp.v10.i8.187. PMID: 32874956; PMCID: PMC7439299. [cited 2022 June 20]
28. Ridaura V, Belkaid Y. Gut microbiota: the link to your second brain. Cell. 2015 Apr 9;161(2):193-4. doi: 10.1016/j.cell.2015.03.033. PMID: 25860600. [cited 2022 June 20]
29. Clapp M, Aurora N, Herrera L, Bhatia M, Wilen E, Wakefield S. Gut microbiota’s effect on mental health: The gut-brain axis. Clin Pract. 2017;7(4):987. Published 2017 Sep 15. doi:10.4081/cp.2017.987 [cited 2022 June 20]
30. Zhang S, Chen DC. Facing a new challenge: the adverse effects of antibiotics on gut microbiota and host immunity. Chin Med J (Engl). 2019;132(10):1135-1138. doi:10.1097/CM9.0000000000000245 [cited 2022 June 20]
31. Crinnion WJ. Environmental medicine, part one: the human burden of environmental toxins and their common health effects. Altern Med Rev. 2000 Feb;5(1):52-63. PMID: 10696119. [cited 2022 June 20]
32. Gu S, Huang R, Yang J, Sun S, Xu Y, Zhang R, Wang Y, Lu B, He T, Wang A, Bian G, Wang Q. Exposure-lag-response association between sunlight and schizophrenia in Ningbo, China. Environ Pollut. 2019 Apr;247:285-292. doi: 10.1016/j.envpol.2018.12.023. Epub 2019 Jan 14. PMID: 30685669. [cited 2022 June 20]